Clinical Trials Logo

Skin Condition clinical trials

View clinical trials related to Skin Condition.

Filter by:

NCT ID: NCT06306105 Recruiting - Skin Condition Clinical Trials

Assessment of Anti-aging Efficacy of Marine Collagen Peptides

Start date: March 4, 2024
Phase: N/A
Study type: Interventional

To assess the anti-aging efficacy of Marine Collagen Peptides on skin, hair and finger nails for human

NCT ID: NCT06237036 Completed - Skin Diseases Clinical Trials

Clinical Validation of AI-Based System for Continuous Remote Monitoring of Patient Severity

COVIDX_EVCDAO
Start date: March 3, 2022
Phase:
Study type: Observational

The goal of this observational prospective and analytical study is to evaluate the effectiveness of the device developed by Legit.Health in remotely monitoring the severity of chronic dermatologic pathologies. Secondly, to assess patient satisfaction with the device for remote monitoring. All this in patients diagnosed with any of the specified chronic dermatological conditions that meet the inclusion criteria. These patients are attended at the Dermatology Department of the Hospital Universitario de Torrejón. The study proceeded as follows: Patient Selection and Recruitment Visit The recruitment period spanned six months, during which investigators identified eligible patients. The Principal Investigator (PI) or designated collaborating investigators explained the study details to potential participants using the Patient Information Sheet. Patients had the opportunity to seek clarification on any aspects of the study. If a patient chose to participate, they provided informed consent and received a study code. Data collection commenced post-consent. During this initial visit, patients used the device under the supervision of the research team to complete questionnaires and capture photographs associated with their pathology. Subsequently, the patient autonomously and remotely continued the data collection process at home, as detailed in the following section. The device was provided at no cost to patients and the research team for the study's duration. Procedures Performed by the Patient at Home Completion of Questionnaires Patients independently reported on their condition from home, following instructions provided by the research team and the "Patient Information Guide" integrated into Legit.Health, in conjunction with photograph submissions. Every two months, patients completed the "Patient Satisfaction Questionnaire" addressing general user experience aspects. Additionally, they completed the System Usability Scale (SUS) Questionnaire at the same frequency Image capture Patients simultaneously took photographs of the affected areas while completing questionnaires through the app. These photographs were captured using the patient's smartphone from their homes in an autonomous manner. The frequency of photograph submission was determined by the consulting specialist. No specialized camera equipment was required; patients used the camera available on their smartphones. Patients then transmitted these photographs to the research team through a web app Both patients and members of the medical team possessed access credentials. The manufacturer did not have access to patient accounts or information. Data transfer and photograph storage adhered to the European Regulation 2016/679 of 27 April on the protection of natural persons with regard to the processing of personal data and the free movement of such data, as well as the Organic Law 3/2018 of 5 December on the Protection of Personal Data and guarantee of digital rights.

NCT ID: NCT06228014 Recruiting - Skin Diseases Clinical Trials

Pilot Study: AI Algorithm for Dermatology Referral Optimization

DAO_DERIVATION
Start date: April 7, 2022
Phase:
Study type: Observational

The goal of this observational prospective and analytical study is to validate that the device is a valid tool for improving the adequacy of referrals to dermatology. As a secondary objectives the investigators set out to validate that the device reduces costs in secondary care; to validate that the device reduces dermatology waiting lists and to validate that the device optimizes clinical flow in Osakidetza. The primary care physician will explain to the patient what his/her participation in the study will consist of by means of the Patient Information Sheet. The patient, in turn, will be able to ask all the questions he/she considers appropriate in order to clarify all his/her doubts regarding the study. If the patient wishes to participate in the study, he/she will sign the Informed Consent Form and will be assigned a study code. After signing the informed consent, the data collection process begins. The Principal Investigator and/or collaborating investigators assigned to this task will collect demographic data (age, sex) and data related to the diagnosis, characteristics and treatment of the pathology. Primary care physicians should take photographs showing the areas affected by the pathology. These photographs will be taken with their own smartphone or using a mobile dermatoscope if the use of a mobile dermatoscope is clinically relevant. The primary care physician, will record the photographs periodically, uploading the images to a Google Drive folder that the study sponsor will enable at the beginning of the study. The photographs are named using a code that includes the patient ID (NNN) and photograph number (nn). Primary care physicians will assess the patient's pathology as they would in a routine consultation and record their diagnosis and referral criteria, and associate them with the patient's photographs and demographic data to be collected by the research team telematically at the end of the study duration. These information transfers and the storage of the photographs will be in line with the European Regulation 2016/679 of 27 April on the protection of natural persons with regard to the processing of personal data and the free movement of such data and the Organic Law 3/2018 of 5 December on the Protection of Personal Data and guarantee of digital rights. The specialist physicians will have a period of one month after the end of the recruitment period to evaluate and label the photographs taken. In this labeling process they will record their diagnosis, and whether they consider that the referral has been appropriate or not. This information will be collected by the research team telematically at the end of the study duration. This transfer of information and storage of the photographs will comply with European Regulation 2016/679, of 27 April, on the protection of natural persons with regard to the processing of personal data and the free movement of such data and with Organic Law 3/2018, of 5 December, on the Protection of Personal Data and guarantee of digital rights.

NCT ID: NCT06194487 Completed - Skin Condition Clinical Trials

Efficacy Evaluation of Collagen Drink Products

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

To assess MAXI Collagen drink on skin condition improvement

NCT ID: NCT06166342 Recruiting - Skin Condition Clinical Trials

Efficacy Evaluation of TCI153 Probiotics for Skin Beautification

Start date: September 15, 2023
Phase: N/A
Study type: Interventional

To assess TCI153 prebiotics product on skin condition improvement

NCT ID: NCT06157567 Recruiting - Wrinkle Clinical Trials

Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System

Start date: May 24, 2022
Phase: N/A
Study type: Interventional

This is a non-randomized, multi-center, open-label clinical trial evaluating clinical feasibility treatments with the Profound Matrix system.

NCT ID: NCT06066151 Recruiting - Anemia Clinical Trials

The Efficacy of Minayo Iron-rich Yeast Drink With SOD on Female Nutritional Anemia, Skin Condition and Qi-blood Deficiency Syndrome

Start date: September 10, 2023
Phase: N/A
Study type: Interventional

The goal of this single arm, open-label study is to learn about the efficacy of Minayo Iron-rich Yeast Drink with SOD on females who are aged 18-35 and suffer nutritional Anemia, skin condition and Qi-blood deficiency syndrome. The main question it aims to answer is: - whether the serum ferritin level in blood is improved after the intervention 14 qualified participants will be enrolled to drink the product "Minayo Iron-rich Yeast Drink with SOD" for four weeks, once a day. Four site visits will be made for each participant so that all relevant clinical data will be captured and recorded for data analysis and reporting. Researchers will compare the final blood test result (hemoglobin concentration level, Glutathione (GSH), Superoxide Dismutase (SOD)) against the baseline to conclude whether the product will be effective in improving Anemia and skin conditions.

NCT ID: NCT05988567 Completed - Skin Condition Clinical Trials

Efficacy Testing of Melon Oil Olive Pressed Candy Products

Start date: May 9, 2023
Phase: N/A
Study type: Interventional

To assess melon and oil olive pressed candy on skin condition improvement

NCT ID: NCT05988554 Completed - Skin Condition Clinical Trials

Efficacy Testing of Hibiscus Sabdariffa Extract and Collagen Products

Start date: June 5, 2023
Phase: N/A
Study type: Interventional

To assess Hibiscus sabdariffa extract and collagen products on skin condition improvement

NCT ID: NCT05789368 Completed - Skin Condition Clinical Trials

Efficacy Testing of VeCollal Products

Start date: February 6, 2023
Phase: N/A
Study type: Interventional

To assess VeCollal formula on skin condition improvement